Guillermo Antinolo
gantinolo.bsky.social
Guillermo Antinolo
@gantinolo.bsky.social
Head of Department of materno-fetal medicine, genetics and reproduction in university hospital Virgen del Rocío. Sevilla, Spain.
Professor of Obstetrics and Gynecology at the University of Seville. Director of FIRST and Foresight, Medicine and Innovation.
January 27, 2025 at 11:34 AM
Reposted by Guillermo Antinolo
The world will not be destroyed by those who do evil, but by those who watch them without doing anything."
- Albert Einstein
This quote by Einstein calls for courage, responsibility, and the strength to stand up for what is right. How will you take a stand today?
January 27, 2025 at 9:51 AM
Reposted by Guillermo Antinolo
“Menopause is a natural evolution of our power. When we stand together, we normalize the conversation and lift each other higher. #BreakTheStigma #SistersInChange
January 27, 2025 at 9:28 AM
Reposted by Guillermo Antinolo
High impact of the genetic diagnosis. This information to evaluate familial implications, such as identification of at-risk family members, guidance for reproductive decisions or treatment recommendations. genetic data guided informed clinical decisions for 1084 patients across many disease groups.
January 21, 2025 at 5:58 PM
Reposted by Guillermo Antinolo
Assisted Variant prioritization with the MMP application, developed bythe Platform of Computational Medicine. Improved and faster disgnosis rate, with a gradual expansion of the number of rare diseases analysed.
January 21, 2025 at 5:58 PM
Reposted by Guillermo Antinolo
Finally our collaborative paper "A genomic strategy for precision medicine in rare diseases" is out translational-medicine.biomedcentral.com/articles/10.... An innovative strategy for diagnosis of #RareDisease patients, with more than 6,500 individuals analysed in the last years.
A genomic strategy for precision medicine in rare diseases: integrating customized algorithms into clinical practice - Journal of Translational Medicine
Background Despite the use of Next-Generation Sequencing (NGS) as the gold standard for the diagnosis of rare diseases, its clinical implementation has been challenging, limiting the cost-effectivenes...
translational-medicine.biomedcentral.com
January 21, 2025 at 5:58 PM
Reposted by Guillermo Antinolo
Starting the year with a region-wise (>500.000 individuals) study exploring implications of hormonal transition on women’s health, leveraging the potential of #RWD. Significant chages in comorbidities observed. www.medrxiv.org/content/10.1... #preventivemedicine @inespinedatorra.bsky.social
January 7, 2025 at 9:51 AM